Annie Mitsak
Private Equity Analist bij Omega Fund Management LLC
Oorsprong van het eerstegraads netwerk van Annie Mitsak
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US.
24
| Private Company | Investment Managers | 24 |
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts.
11
| Private Company | Investment Managers | 11 |
| Public Company | Biotechnology | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Annie Mitsak via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chairman | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman | |
| Henley Business School Ltd. | College/University | Masters Business Admin | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Director of Finance/CFO | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| HARBOES BRYGGERI A/S | Beverages: Alcoholic | Director/Board Member | |
| Boston University | College/University | Graduate Degree Graduate Degree | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Toronto | College/University | Doctorate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Corporate Officer/Principal | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Chairman | |
| University of Copenhagen | College/University | Undergraduate Degree | |
| University of Pavia | College/University | Graduate Degree Doctorate Degree | |
| University of Geneva | College/University | Doctorate Degree Doctorate Degree | |
| NeoMed S.à.r.l. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
American Association of Pharmaceutical Scientists
 American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Plougmann, Vingtoft & Partners A/S | Corporate Officer/Principal | ||
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Director/Board Member | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member | |
| Statens Serum Institute | College/University | Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
Lundbeckfonden Ventures
 Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark. | Investment Managers | Private Equity Investor | |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ESSA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Danish BioVenture General Partner ApS
 Danish BioVenture General Partner ApS Financial ConglomeratesFinance Danish BioVenture General Partner ApS operates as a general partner and renders investment advice to K/S Danish BioVenture. It manages the administration and acts as a representative of Danish BioVenture in external commercial relations. The company was founded on June 26, 2009 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Graduate Degree | |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
Andrew Alliance SA
 Andrew Alliance SA Industrial MachineryProducer Manufacturing Andrew Alliance SA develops liquid handling solutions. Its product, Andrew, is a novel liquid handling robot designed for pipetting process. The firm's products include Andrew models, consumable dominos, protocol design, and enabling accessories. The company was founded by Piero Zucchelli, Giorgio Horak, and Antoine Jordan in March 2011 and is headquartered in Vernier, Switzerland. | Industrial Machinery | Director/Board Member Director/Board Member | |
| GOSSAMER BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Chord Therapeutics SA
 Chord Therapeutics SA BiotechnologyHealth Technology Chord Therapeutics SA is a clinical stage pharmaceutical company. It develops drugs for patients with rare, life-threatening and severely disabling diseases. The firm offers CRD1. The company was founded by Arthur Roach and is headquartered in Geneva, Switzerland. | Biotechnology | Chairman Director/Board Member | |
| OMEGA ALPHA SPAC | Financial Conglomerates | Founder Chief Executive Officer Founder Founder | |
| LEXEO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
NRG Therapeutics Ltd.
 NRG Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services NRG Therapeutics Ltd. is a British neuroscience drug discovery company that focuses on building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and ALS. The company is based in Stevenage, UK, and was founded in 2018 by Neil Miller and Richard Rutter. The company's pre-clinical pipeline of small molecule assets is based on inhibiting the mitochondrial permeability transition pore (mptp) through a novel mechanism of action. Inhibition of the mptp has been shown to protect neurons, reduce neuroinflammation, and extend survival in pre-clinical disease models. Neil Miller has been the CEO since 2018. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Chairman | |
Xenimmune Therapeutics, Inc.
 Xenimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xenimmune Therapeutics, Inc. develops antibody-enzyme fusion to target tumors and trigger the hyper-acute rejection. The private company is located in the US. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tasca Therapeutics Corp.
 Tasca Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Tasca Therapeutics Corp. develops molecule drugs. The American company was founded by Milenko Cicmil, David E. Fisher, Duojia Pan, Xu Wu. Milenko Cicmil has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Founder | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Director of Finance/CFO Private Equity Investor |
Statistieken
Internationaal
| Verenigde Staten | 29 |
| Denemarken | 10 |
| Zwitserland | 6 |
| Verenigd Koninkrijk | 4 |
| Canada | 3 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 12 |
| Finance | 8 |
| Commercial Services | 4 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 246 |
| Corporate Officer/Principal | 81 |
| Independent Dir/Board Member | 53 |
| Private Equity Investor | 51 |
| Undergraduate Degree | 31 |
Sterkste connecties
| Insiders | |
|---|---|
| Michael Powell | 48 |
| John Maraganore | 38 |
| Otello Stampacchia | 37 |
| Mette Agger | 30 |
| Claudio Nessi | 25 |
| Anne VanLent | 23 |
| Dina Chaya | 23 |
| Vincent Ossipow | 22 |
| Jeff Jonas | 21 |
| Eran Nadav | 21 |
| Bernard Davitian | 19 |
| Richard Lim | 17 |
| David Fallace | 16 |
| Lou Tartaglia | 15 |
| Roshawn Blunt | 14 |
- Beurs
- Insiders
- Annie Mitsak
- Bedrijfsconnecties
